Onconetix, Inc. ONCO revenue by segment, product and geography
In its fiscal year ending 2025-12-31, Onconetix, Inc. reported revenue across 4 products and services; the largest, Other Revenues, was $588K, 72.1% of the filed sum.
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Other Revenues$588K72.1%no prior
- Product Sales$226K27.7%-9.3% yoy
- Development Service$1.65K0.2%-99.9% yoy
- License$0.60.0%no prior
Members sum to the consolidated $815K for this period.
- Switzerland$797Kshare n/a-67.3% yoy
- European Union$797Kshare n/a-67.3% yoy
- Non European Union$18.8Kshare n/a-21.2% yoy
- United Kingdom$18.8Kshare n/a-21.2% yoy
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- United Kingdom$21.5K100.0%+196.1% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.